Clinical trials
Nephritis, Hereditary trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 2 |
| Genzyme, a Sanofi Company | 2 |
| Bayer | 1 |
| Calliditas Therapeutics AB | 1 |
| Enyo Pharma | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| River 3 Renal Corp. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nephritis, Hereditary | 9 |
| Kidney Diseases | 4 |
| Glomerulosclerosis, Focal Segmental | 1 |
| Nephritis | 1 |
| Polycystic Kidney, Autosomal Dominant | 1 |
| Rare Diseases | 1 |
| Renal Insufficiency, Chronic | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.